These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10485492)

  • 1. The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues.
    Till KJ; Zuzel M; Cawley JC
    Cancer Res; 1999 Sep; 59(17):4419-26. PubMed ID: 10485492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 mediates polymorphonuclear leukocyte motility on hyaluronan.
    Aziz KA
    Saudi Med J; 2003 Aug; 24(8):827-31. PubMed ID: 12939665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
    Turley EA; Austen L; Moore D; Hoare K
    Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways.
    Slevin M; Krupinski J; Gaffney J; Matou S; West D; Delisser H; Savani RC; Kumar S
    Matrix Biol; 2007 Jan; 26(1):58-68. PubMed ID: 17055233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Mertens D; Bühler A; Barth TF; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
    Leukemia; 2009 Mar; 23(3):519-27. PubMed ID: 19092852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
    Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia.
    Aziz KA; Till KJ; Zuzel M; Cawley JC
    Blood; 2000 Nov; 96(9):3161-7. PubMed ID: 11049998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-transformed cells.
    Yang B; Hall CL; Yang BL; Savani RC; Turley EA
    J Cell Biochem; 1994 Dec; 56(4):455-68. PubMed ID: 7534313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM.
    Turley EA; Hossain MZ; Sorokan T; Jordan LM; Nagy JI
    Glia; 1994 Sep; 12(1):68-80. PubMed ID: 7531178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis.
    Nasreen N; Mohammed KA; Hardwick J; Van Horn RD; Sanders K; Kathuria H; Loghmani F; Antony VB
    Oncol Res; 2002; 13(2):71-8. PubMed ID: 12392154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins.
    Fujisaki T; Tanaka Y; Fujii K; Mine S; Saito K; Yamada S; Yamashita U; Irimura T; Eto S
    Cancer Res; 1999 Sep; 59(17):4427-34. PubMed ID: 10485493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.
    Spessotto P; Zucchetto A; Degan M; Wasserman B; Danussi C; Bomben R; Perris R; Canzonieri V; Radillo O; Colombatti A; Gattei V
    Matrix Biol; 2007 Jul; 26(6):473-84. PubMed ID: 17482449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new polyclonal antibody that recognizes a human receptor for hyaluronan mediated motility.
    Kuwabara H; Yoneda M; Nagai M; Hayasaki H; Mori H
    Cancer Lett; 2004 Jul; 210(1):73-80. PubMed ID: 15172123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
    López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
    J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage.
    Julovi SM; Yasuda T; Shimizu M; Hiramitsu T; Nakamura T
    Arthritis Rheum; 2004 Feb; 50(2):516-25. PubMed ID: 14872494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
    Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
    Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
    Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
    Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
    Singleton PA; Bourguignon LY
    Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting the differentiation of myocardiocytes by hyaluronic acid.
    Iocono JA; Bisignani GJ; Krummel TM; Ehrlich HP
    J Surg Res; 1998 May; 76(2):111-6. PubMed ID: 9698509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.